Newsroom
Sorted by: Latest
-
Everspin to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
CHANDLER, Ariz.--(BUSINESS WIRE)--Everspin will participate in the Lytham Partners 2026 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 18, 2026....
-
TAGRISSO® (osimertinib) plus savolitinib demonstrated statistically significant and clinically meaningful improvements in progression-free and overall survival in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the SAFFRON Phase III trial showed TAGRISSO® (osimertinib) plus savolitinib demonstrated a statistically significant and clinically meaningful improvement in both progression-free survival (PFS) and overall survival (OS) versus doublet platinum-based chemotherapy in patients with epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). Patients in the trial had tumors with high levels of MET overexpr...
-
Dynatrace Announces Proposed Private Placement of $1.25 Billion of Exchangeable Senior Notes
BOSTON--(BUSINESS WIRE)--Dynatrace, Inc. (“Dynatrace”) (NYSE: DT), the leading AI-powered observability platform, today announced that its indirect wholly-owned subsidiary, Dynatrace LLC (the “Issuer”), intends to offer, subject to market conditions and other factors, $1.25 billion aggregate principal amount of its Exchangeable Senior Notes due 2031 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A und...
-
D-Wave Appoints Kevan P. Krysler to Board of Directors and Audit Committee
PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NASDAQ: QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced the appointment of veteran technology finance executive Kevan P. Krysler to its Board of Directors and Audit Committee. Krysler currently serves as chief financial officer of Carbon Robotics, a privately held company specializing in physical AI and robotics for...
-
Great Hill Partners Appoints Sam Liu as Director of AI
BOSTON--(BUSINESS WIRE)--Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies, today announced that Sam Liu has joined the firm’s Growth Team as Director of AI, reflecting Great Hill’s continued focus on applying AI across the full scope of its investment and value creation activities. In this role, Liu will partner with Great Hill’s investment professionals to further develop the firm’s AI capabilities, combining technology and repeatable processes to st...
-
United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced full enrollment of its TETON-PPF study evaluating the use of Tyvaso® (treprostinil) inhalation solution (nebulized Tyvaso) for the treatment of progressive pulmonary fibrosis (PPF). The TETON-PPF study enrolled 754 patients. “The rapid pace of enrollment underscores both the significant unmet need for new treatment options in PPF and the strong interest in nebulized Tyvas...
-
First Bellwether Trial Today Against Reckitt Benckiser’s Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio
PENSACOLA, Fla.--(BUSINESS WIRE)--Reckitt Benckiser (LON: RKT) subsidiary, Mead Johnson is facing the first bellwether today as part of a multidistrict litigation (MDL) in the US District Court for the Northern District of Illinois over its infant formula Enfamil being linked to necrotizing enterocolitis (NEC) in a premature infant. Inman v. Mead Johnson & Company, LLC, et al. is the first case against Mead Johnson in the MDL to proceed to trial. NEC is a severe intestinal disease that can...
-
Barings Global Short Duration High Yield Fund Announces August 2026 Monthly Distribution of $0.1223 per Share
CHARLOTTE, N.C.--(BUSINESS WIRE)--The Barings Global Short Duration High Yield Fund (the “Fund”) (NYSE: BGH) announced its monthly dividend for August 2026 of $0.1223 per share, payable on September 1, 2026. Based on the Fund’s July 31, 2026 share price of $14.03 per share, the dividend represents an annualized yield of 10.46% per share. Based on current projections through the payable date, the Fund expects that this dividend will be comprised of net investment income. In addition, the Fund an...
-
From Retail Regret to Retail Redemption: How JCPenney Is Healing America's Shopping
PLANO, Texas--(BUSINESS WIRE)--JCPenney is taking shoppers from retail regret to retail redemption, offering value-driven customers a better way to shop for quality and fashion....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Capital Strength UCITS ETF 14.08.2026 FTCS. IE00BL0L0D23 250,002.00 USD 8,803,473.34 35.214 ...